Related Experiment Video
Updated: Apr 21, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
17.3K
Aldosterone and the heart: still an unresolved issue?
Cristiana Catena1, GianLuca Colussi1, Francesca Nait1
1Hypertension Unit, Department of Experimental and Clinical Medical Sciences, Clinica Medica, University Hospital, University of Udine , Udine , Italy.
Frontiers in Endocrinology
|October 30, 2014
Summary
Aldosterone activation in the heart can cause damage independently of blood pressure. This review explores aldosterone
Area of Science:
- Cardiology
- Endocrinology
- Molecular Biology
Background:
- Mineralocorticoid hormone receptors are present in myocardial cells.
- Animal studies suggest aldosterone receptor activation causes cardiac damage independent of blood pressure.
- Aldosterone's cardiac effects are investigated in heart failure, arrhythmia, and hypertension.
Purpose of the Study:
- To review recent findings on aldosterone's contribution to cardiac function.
- To examine aldosterone's influence on left ventricular structure and function in primary hypertension and primary aldosteronism.
- To clarify the role of aldosterone blockade in cardiovascular disease prevention and treatment.
Main Methods:
- Overview of recent animal studies on aldosterone and cardiac function.
- Review of clinical studies on aldosterone's effects in primary hypertension and primary aldosteronism.
- Synthesis of current knowledge on aldosterone's role in cardiovascular diseases.
Main Results:
- Aldosterone activation can lead to cardiac damage independent of blood pressure.
- Clinical studies focus on aldosterone's impact in various cardiovascular conditions.
- Further clarification is needed regarding aldosterone blockade's therapeutic potential.
Conclusions:
- Aldosterone plays a significant role in cardiac function and structure.
- Understanding aldosterone's mechanisms is crucial for cardiovascular disease management.
- Aldosterone blockade may offer therapeutic benefits, warranting further investigation.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
01:33Hormonal Regulation
29.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
29.9K
01:22Heart Failure Drugs: Diuretics
1.3K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.3K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K